Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Profiling cell-free DNA To Better Understand Clinical Pathologies Immune Response and Disease Progression

Wednesday, August 6, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster titled 'Profiling cell-free DNA To Better Understand Clinical Pathologies Immune Response and Disease Progression' presents research focused on the role of cell-free DNA in understanding immune responses and disease progression. The authors include Theresa K Kelly and others, and the work may offer prognostic insights relevant to clinical pathologies. Related articles discuss the prognostic value of the Nu.Q® Cancer Test.
Price reaction · baseline $12.8 (2025-08-05 close) · hit pre-market · 3 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
+4.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • The poster presents innovative research on cell-free DNA.
  • It aims to enhance understanding of immune responses and disease progression.
  • The study may provide valuable prognostic insights for clinical pathologies.

Full Press Release Details

Poster titled: Profiling cell-free DNA To Better Understand Clinical Pathologies Immune Response and Disease Progression
Theresa K Kelly, Christina Wheeler, Finley Serneo, Sharon Ballesteros, Justin Cayford, Andrew Retter, Benjamin P. Berman

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of the poster presented?

The poster focuses on profiling cell-free DNA to understand immune responses and disease progression.

Who are the authors of the poster?

The authors include Theresa K Kelly, Christina Wheeler, and others.

What potential insights does the research aim to provide?

The research aims to provide prognostic insights relevant to clinical pathologies.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare cell-free DNA immune response disease progression clinical pathologies
Last updated: Aug 6, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk